Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katsuma, Tani"'
Autor:
Tomohiro Urata, Kazutaka Sunami, Toshi Imai, Yuichiro Nawa, Yasushi Hiramatsu, Kazuhiko Yamamoto, Soichiro Fujii, Isao Yoshida, Tomofumi Yano, Yusuke Naoi, Kazuhiro Ikeuchi, Hiroki Kobayashi, Katsuma Tani, Shuji Momose, Jun-ichi Tamaru, Merrill Boyle, Aixiang Jiang, Yasuharu Sato, Tadashi Yoshino, Yoshinobu Maeda, David W. Scott, Daisuke Ennishi
Publikováno v:
Blood. 140:6421-6423
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c8f37a7f17c7a23362790f1734eae7d
https://doi.org/10.1182/blood-2022-157702
https://doi.org/10.1182/blood-2022-157702
Autor:
Sachiyo, Okamoto, Ken-Ichi, Matsuoka, Maiko, Sakamoto, Yoshiaki, Usui, Yuki, Fujiwara, Takumi, Kondo, Katsuma, Tani, Kyosuke, Saeki, Yusuke, Meguri, Noboru, Asada, Daisuke, Ennishi, Hisakazu, Nishimori, Keiko, Fujii, Nobuharu, Fujii, Yoshinobu, Maeda
Publikováno v:
Acta Medica Okayama. 73(2):161-171
Second allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for patients who relapse after first allo-SCT. Human leukocyte antigen (HLA)-haploidentical related donors provide the broad opportunity to conduct second SCT at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dd87d431181b8b662c0851c2c9a07586
https://ousar.lib.okayama-u.ac.jp/56652
https://ousar.lib.okayama-u.ac.jp/56652
Autor:
Wataru, Kitamura, Takuya, Machida, Keigo, Fujishita, Satoshi, Oka, Yuka, Fujisawa, Katsuma, Tani, Toshi, Imai
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(4)
We present the case of a 39-year-old man with a primary diagnosis of mixed phenotype acute leukemia, T/myeloid not otherwise specified (T/M-MPAL). After achieving a complete remission (CR), he underwent allogeneic hematopoietic stem cell transplantat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67fb52ab489eee6fe5337f49c0665539
https://pubmed.ncbi.nlm.nih.gov/32378572
https://pubmed.ncbi.nlm.nih.gov/32378572
Autor:
Nobuharu Fujii, Hisakazu Nishimori, Ken-ichi Matsuoka, Hideaki Fujiwara, Katsuma Tani, Yoshinobu Maeda, Eisei Kondo, Mitsune Tanimoto, Tatsunori Ishikawa, Makoto Nakamura, Yasuhisa Sando
Publikováno v:
Transfusion. 56:886-892
BACKGROUND Transplant-associated thrombotic microangiopathy (TA-TMA) after hematopoietic stem cell transplantation (HSCT) remains a severe complication associated with underlying endothelial damage. TMA has a high mortality rate with no definite trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d8c1f69b708fdaf2a3e1a6bef8102a
https://doi.org/10.1111/trf.13437
https://doi.org/10.1111/trf.13437
Autor:
Katsuma Tani, Naoe Takagi, Naomi Asano, Toru Ikeda, Nobuharu Fujii, Kyousuke Saeki, Keiko Fujii, Yuki Hinokuchi, Hiroaki Ogo, Makoto Nakamura
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 63:727-728
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eeacd680074968b0ebbfe5b0611e11c
https://doi.org/10.3925/jjtc.63.727
https://doi.org/10.3925/jjtc.63.727
Autor:
Shohei Yoshida, Yoshinobu Maeda, Taiga Kuroi, Keisuke Seike, Kyosuke Saeki, Hisakazu Nishimori, Mitsune Tanimoto, Katsuma Tani
Publikováno v:
Blood. 128:3351-3351
Chronic graft-versus-host disease (GVHD) remains a major late complication of allogeneic hematopoietic stem cell transplantation (HSCT). Prolonged administration of a calcineurin inhibitor, such as cyclosporin A (CsA), does not decrease the risk of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04af114be3d53b6d34ca2bf2b258342e
https://doi.org/10.1182/blood.v128.22.3351.3351
https://doi.org/10.1182/blood.v128.22.3351.3351
Autor:
Hideaki Fujiwara, Katsuma Tani, Eisei Kondo, Hisakazu Nishimori, Takanori Ishikawa, Nobuharu Fujii, Yasuhisa Sando, Mitsune Tanimoto, Ken-ichi Matsuoka, Yoshinobu Maeda, Makoto Nakamura
Publikováno v:
Blood. 124:1141-1141
Background and Objectives: Thrombotic microangiopathy (TMA) after hematopoietic stem cell transplantation (SCT) is a devastating complication of SCT and lacks optimal managements with a high mortality. Its pathogenesis is not well understood but sugg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3692b1378aa485eb1bcac07ef709eeb9
https://doi.org/10.1182/blood.v124.21.1141.1141
https://doi.org/10.1182/blood.v124.21.1141.1141